Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

181

LDV PartnersLatest Sep 22

Primrose Bio · Undisclosed Growth financing Spot Biosystems · $40M Series B

2rounds

0led

Biotech 2

Growth 1, Series B 1

Sep 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Growth 1, Series B 1

Primrose Bio Undisclosed Growth financing Spot Biosystems $40M Series B

182

Elmstead PartnersLatest Sep 21

Axio BioPharma · $2.4M Pre-seed Autoimmunity BioSolutions · $1M Seed extension

2rounds

—led

Biotech 1Enterprise software 1

Pre-seed 1, Seed 1

Sep 21, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Seed 1

Axio BioPharma $2.4M Pre-seed Autoimmunity BioSolutions $1M Seed extension

183

New Science VenturesLatest Sep 21

Novadip Biosciences · €10.4M Convertible financing Trellis Bioscience · $9M Series C

2rounds

1led

Biotech 2

Series C+ 1, Undisclosed 1

Sep 21, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Novadip Biosciences €10.4M Convertible financing Trellis Bioscience $9M Series C

184

Wallonie EntreprendreLatest Sep 21

Novadip Biosciences · €10.4M Convertible financing Enodia Therapeutics · €20.7M Seed

2rounds

0led

Biotech 2

Seed 1, Undisclosed 1

Sep 21, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Novadip Biosciences €10.4M Convertible financing Enodia Therapeutics €20.7M Seed

185

Mesa Verde Venture PartnersLatest Sep 18

Tempo Therapeutics · $14.5M Funding Acurion · $4.3M Seed

2rounds

0led

Biotech 1Healthtech 1

Seed 1, Undisclosed 1

Sep 18, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Tempo Therapeutics $14.5M Funding Acurion $4.3M Seed

186

IDG CapitalLatest Sep 16

Anew Labs · $290M Funding Spot Biosystems · $40M Series B

2rounds

1led

Biotech 2

Series B 1, Undisclosed 1

Sep 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Anew Labs $290M Funding Spot Biosystems $40M Series B

187

Scottish EnterpriseLatest Sep 16

Chemify · £22M £22 million grant package Biocaptiva · £15.8M Series A

2rounds

0led

Biotech 1Industrial tech 1

Series A 1, Undisclosed 1

Sep 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Chemify £22M £22 million grant package Biocaptiva £15.8M Series A

188

The Column GroupLatest Sep 16

Circle Pharma, Inc. · $92.5M Series E InduPro · $77M Series B

2rounds

1led

Biotech 2

Series B 1, Series C+ 1

Sep 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Circle Pharma, Inc. $92.5M Series E InduPro $77M Series B

189

AV8 VenturesLatest Sep 14

Shennon Biotechnologies · $12M Funding Think Bioscience · $55M Series A

2rounds

0led

Biotech 2

Series A 1, Undisclosed 1

Sep 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Shennon Biotechnologies $12M Funding Think Bioscience $55M Series A

190

CDP Venture CapitalLatest Sep 14

Ferm Labs · €3M Seed Algorithmiq · €18M Series B

2rounds

1led

Developer tools 1Foodtech 1

Seed 1, Series B 1

Sep 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series B 1

Ferm Labs €3M Seed Algorithmiq €18M Series B

191

Future VenturesLatest Sep 14

Shennon Biotechnologies · $12M Funding Moonwalk Biosciences · $70M Series B

2rounds

0led

Biotech 2

Series B 1, Undisclosed 1

Sep 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Shennon Biotechnologies $12M Funding Moonwalk Biosciences $70M Series B

192

CDTI InnvierteLatest Sep 10

Connecta Therapeutics · €3.1M Clinical development financing MOA Foodtech · €3.3M €3.3 million financing round

2rounds

0led

Biotech 1Foodtech 1

Undisclosed 2

Sep 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

Connecta Therapeutics €3.1M Clinical development financing MOA Foodtech €3.3M €3.3 million financing round

193

Clave CapitalLatest Sep 10

Connecta Therapeutics · €3.1M Clinical development financing Pharmacelera · €6M Growth

2rounds

1led

Biotech 2

Growth 1, Undisclosed 1

Sep 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Growth 1, Undisclosed 1

Connecta Therapeutics €3.1M Clinical development financing Pharmacelera €6M Growth

194

InvereadyLatest Sep 10

Connecta Therapeutics · €3.1M Clinical development financing Pharmacelera · €6M Growth

2rounds

0led

Biotech 2

Growth 1, Undisclosed 1

Sep 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Growth 1, Undisclosed 1

Connecta Therapeutics €3.1M Clinical development financing Pharmacelera €6M Growth

195

NRW.BANKLatest Sep 10

Phagestack · Undisclosed NRW.BANK investment Cellbox Solutions · €5M Series A — €5m final close October 2026

2rounds

0led

Biotech 2

Series A 1, Undisclosed 1

Sep 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Undisclosed 1

Phagestack Undisclosed NRW.BANK investment Cellbox Solutions €5M Series A — €5m final close October 2026

196

2048 VenturesLatest Sep 9

TwoStep Therapeutics · $62.5M Series A Century Health · $5M Seed

2rounds

—led

Biotech 1Healthtech 1

Seed 1, Series A 1

Sep 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

TwoStep Therapeutics $62.5M Series A Century Health $5M Seed

197

Carma FundLatest Sep 9

Allogenetics · €3.8M Pre-Series A Exciva · €51M Series B

2rounds

0led

Biotech 2

Series A 1, Series B 1

Sep 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Allogenetics €3.8M Pre-Series A Exciva €51M Series B

198

Medical Excellence CapitalLatest Sep 9

TwoStep Therapeutics · $62.5M Series A SonoThera · $125M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Sep 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

TwoStep Therapeutics $62.5M Series A SonoThera $125M Series B

199

RTW InvestmentsLatest Sep 9

Encoded Therapeutics Inc. · $275M Series F Amani Therapeutics · $25M Series A

2rounds

0led

Biotech 2

Series A 1, Series C+ 1

Sep 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Encoded Therapeutics Inc. $275M Series F Amani Therapeutics $25M Series A

200

VenrockLatest Sep 9

Encoded Therapeutics Inc. · $275M Series F Adcendo · $75M Series C

2rounds

0led

Biotech 2

Series C+ 2

Sep 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Encoded Therapeutics Inc. $275M Series F Adcendo $75M Series C

201

AbbVie VenturesLatest Sep 8

Cloverleaf Bio · $33M Seed Third Arc Bio · $52M Series A+

2rounds

0led

Biotech 2

Seed 1, Series A 1

Sep 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Cloverleaf Bio $33M Seed Third Arc Bio $52M Series A+

202

Alpha WaveLatest Sep 8

Moonwalk Biosciences · $70M Series B AdvanCell · $315M Series D

2rounds

1led

Biotech 2

Series B 1, Series C+ 1

Sep 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Moonwalk Biosciences $70M Series B AdvanCell $315M Series D

203

European Innovation Council (EIC) FundLatest Sep 7

Vaxdyn · €11M Series A Leyden Laboratories · €40M Series B

2rounds

0led

Biotech 2

Series A 1, Series B 1

Sep 7, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Vaxdyn €11M Series A Leyden Laboratories €40M Series B

204

Perceptive AdvisorsLatest Sep 3

Superluminal Medicines · $60M Series B Vaderis Therapeutics · $152M Series B

2rounds

0led

Biotech 2

Series B 2

Sep 3, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Superluminal Medicines $60M Series B Vaderis Therapeutics $152M Series B

205

SBI US Gateway FundLatest Sep 2

Typewriter Therapeutics · $56M Series A Sift Biosciences · $3.7M Pre-Seed

2rounds

0led

Biotech 2

Pre-seed 1, Series A 1

Sep 2, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Series A 1

Typewriter Therapeutics $56M Series A Sift Biosciences $3.7M Pre-Seed

206

Zürcher KantonalbankLatest Sep 2

DataHow · Undisclosed Bridge financing Alithea Genomics · CHF 3M Seed

2rounds

0led

Biotech 1Enterprise software 1

Seed 1, Undisclosed 1

Sep 2, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

DataHow Undisclosed Bridge financing Alithea Genomics CHF 3M Seed

207

Evoce CapitalLatest Sep 1

Senticell · $7M Seed Surf Therapeutics · $6M Seed

2rounds

0led

Biotech 1Healthtech 1

Seed 2

Sep 1, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 2

Senticell $7M Seed Surf Therapeutics $6M Seed

208

Venture KickLatest Aug 31

PANDA Therapeutics · CHF 100K Venture Kick Stage III NanoZymeX · €160K Pre-Seed

2rounds

0led

Biotech 2

Pre-seed 1, Undisclosed 1

Aug 31, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Undisclosed 1

PANDA Therapeutics CHF 100K Venture Kick Stage III NanoZymeX €160K Pre-Seed

209

HanKang CapitalLatest Aug 27

AusperBio · $120M Series C Vivacta Biotechnology · $50M Series A+

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Aug 27, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

AusperBio $120M Series C Vivacta Biotechnology $50M Series A+

210

InnoPinnacle FundLatest Aug 27

AusperBio · $120M Series C CORE Biomedicine · $21M Series A

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Aug 27, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

AusperBio $120M Series C CORE Biomedicine $21M Series A

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.